Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Deal with Joint Illness – Enveric Biosciences (NASDAQ:ENVB)
On Tuesday, Enveric Biosciences’ ENVB wholly-owned subsidiary, Akos Biosciences, Inc., entered into two licensing agreements with Restoration Biologics LLC, a biotechnology firm targeted on...
GH Analysis Proclaims Pricing of $150 Million Public Providing – GH Analysis (NASDAQ:GHRS)
DUBLIN, Feb. 05, 2025 (GLOBE NEWSWIRE) -- GH Analysis PLC GHRS, a clinical-stage biopharmaceutical firm devoted to remodeling the lives of sufferers...
GSK This autumn Earnings: Income And EPS Beat, Initiates $2.5 Billion Inventory Buyback, Raises Lengthy-Time period Annual Gross sales Forecast To Over $50 Billion...
Wednesday, GSK Plc GSK reported fourth-quarter gross sales of $10.40 billion (8.12 billion Sterling Kilos), up 1% year-over-year and up 4% on fixed forex. The analysts estimated...